Local secretion of anti-CTLA-4 enhances the therapeutic efficacy of a cancer immunotherapy with reduced evidence of systemic autoimmunity.

Source:http://linkedlifedata.com/resource/pubmed/id/18236040

Download in:

View as

General Info

PMID
18236040